373 related articles for article (PubMed ID: 20819065)
1. Modulation of carbonic anhydrase 9 (CA9) in human brain cancer.
Said HM; Supuran CT; Hageman C; Staab A; Polat B; Katzer A; Scozzafava A; Anacker J; Flentje M; Vordermark D
Curr Pharm Des; 2010; 16(29):3288-99. PubMed ID: 20819065
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia induced CA9 inhibitory targeting by two different sulfonamide derivatives including acetazolamide in human glioblastoma.
Said HM; Hagemann C; Carta F; Katzer A; Polat B; Staab A; Scozzafava A; Anacker J; Vince GH; Flentje M; Supuran CT
Bioorg Med Chem; 2013 Jul; 21(13):3949-57. PubMed ID: 23706268
[TBL] [Abstract][Full Text] [Related]
3. Targeting tumor-associated carbonic anhydrase IX in cancer therapy.
Thiry A; Dogné JM; Masereel B; Supuran CT
Trends Pharmacol Sci; 2006 Nov; 27(11):566-73. PubMed ID: 16996620
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase IX: a new druggable target for the design of antitumor agents.
Winum JY; Rami M; Scozzafava A; Montero JL; Supuran C
Med Res Rev; 2008 May; 28(3):445-63. PubMed ID: 17880011
[TBL] [Abstract][Full Text] [Related]
5. Bicarbonate Recycling by HIF-1-Dependent Carbonic Anhydrase Isoforms 9 and 12 Is Critical in Maintaining Intracellular pH and Viability of Nucleus Pulposus Cells.
Silagi ES; Schoepflin ZR; Seifert EL; Merceron C; Schipani E; Shapiro IM; Risbud MV
J Bone Miner Res; 2018 Feb; 33(2):338-355. PubMed ID: 28940640
[TBL] [Abstract][Full Text] [Related]
6. Cancer-associated carbonic anhydrases and their inhibition.
Pastorekova S; Zatovicova M; Pastorek J
Curr Pharm Des; 2008; 14(7):685-98. PubMed ID: 18336315
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase 9 in clear cell renal cell carcinoma: a marker for diagnosis, prognosis and treatment.
Tostain J; Li G; Gentil-Perret A; Gigante M
Eur J Cancer; 2010 Dec; 46(18):3141-8. PubMed ID: 20709527
[TBL] [Abstract][Full Text] [Related]
8. Distinct patterns of hypoxic expression of carbonic anhydrase IX (CA IX) in human malignant glioma cell lines.
Said HM; Staab A; Hagemann C; Vince GH; Katzer A; Flentje M; Vordermark D
J Neurooncol; 2007 Jan; 81(1):27-38. PubMed ID: 16944313
[TBL] [Abstract][Full Text] [Related]
9. HIF-1α inhibition by siRNA or chetomin in human malignant glioma cells: effects on hypoxic radioresistance and monitoring via CA9 expression.
Kessler J; Hahnel A; Wichmann H; Rot S; Kappler M; Bache M; Vordermark D
BMC Cancer; 2010 Nov; 10():605. PubMed ID: 21050481
[TBL] [Abstract][Full Text] [Related]
10. Expression patterns of the hypoxia-related genes osteopontin, CA9, erythropoietin, VEGF and HIF-1alpha in human glioma in vitro and in vivo.
Said HM; Hagemann C; Staab A; Stojic J; Kühnel S; Vince GH; Flentje M; Roosen K; Vordermark D
Radiother Oncol; 2007 Jun; 83(3):398-405. PubMed ID: 17524506
[TBL] [Abstract][Full Text] [Related]
11. DNA damage is a prerequisite for p53-mediated proteasomal degradation of HIF-1alpha in hypoxic cells and downregulation of the hypoxia marker carbonic anhydrase IX.
Kaluzová M; Kaluz S; Lerman MI; Stanbridge EJ
Mol Cell Biol; 2004 Jul; 24(13):5757-66. PubMed ID: 15199132
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating thioureido-sulfanilyl scaffolds.
Puccetti L; Fasolis G; Cecchi A; Winum JY; Gamberi A; Montero JL; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 May; 15(9):2359-64. PubMed ID: 15837325
[TBL] [Abstract][Full Text] [Related]
13. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Sivridis E; Pastorek J; Wykoff CC; Gatter KC; Harris AL
Cancer Res; 2001 Nov; 61(21):7992-8. PubMed ID: 11691824
[TBL] [Abstract][Full Text] [Related]
14. Carbonic anhydrase IX: Biochemical and crystallographic characterization of a novel antitumor target.
De Simone G; Supuran CT
Biochim Biophys Acta; 2010 Feb; 1804(2):404-9. PubMed ID: 19679200
[TBL] [Abstract][Full Text] [Related]
15. Novel sulfonamide compounds for inhibition of metastatic tumor growth (WO2012021963).
Colinas PA
Expert Opin Ther Pat; 2013; 23(6):761-3. PubMed ID: 23566197
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors.
Supuran CT
Expert Opin Investig Drugs; 2018 Dec; 27(12):963-970. PubMed ID: 30426805
[TBL] [Abstract][Full Text] [Related]
17. Hypoxia-regulated carbonic anhydrase-9 (CA9) relates to poor vascularization and resistance of squamous cell head and neck cancer to chemoradiotherapy.
Koukourakis MI; Giatromanolaki A; Sivridis E; Simopoulos K; Pastorek J; Wykoff CC; Gatter KC; Harris AL
Clin Cancer Res; 2001 Nov; 7(11):3399-403. PubMed ID: 11705854
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia inducible factor (HIf1alpha and HIF2alpha) and carbonic anhydrase 9 (CA9) expression and response of head-neck cancer to hypofractionated and accelerated radiotherapy.
Koukourakis MI; Giatromanolaki A; Danielidis V; Sivridis E
Int J Radiat Biol; 2008 Jan; 84(1):47-52. PubMed ID: 17852557
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of carbonic anhydrase and HIF-1α in Wilms tumours.
Dungwa JV; Hunt LP; Ramani P
BMC Cancer; 2011 Sep; 11():390. PubMed ID: 21910893
[TBL] [Abstract][Full Text] [Related]
20. Selective carbonic anhydrase IX inhibitors based on coumarin scaffold as promising antimetastatic agents: WO2012070024.
Carradori S
Expert Opin Ther Pat; 2013; 23(6):751-6. PubMed ID: 23387899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
